The Transversal Services Unit is dedicated to advancing precision oncology, cancer prevention, and biomedical innovation through cutting-edge data analytics, artificial intelligence, bioinformatics and biomedical research support, including animal facility services.

Through the application of biomedical data analysis, artificial intelligence, and computational methods, state-of-the-art in vivo models and preclinical imaging platform (PIP) the unit plays a crucial role in shaping the future of cancer research and positioning VHIO at the forefront of oncological innovation.

By combining these technologies and biomedical research capabilities, the unit strengthens VHIO’s leadership in translational cancer research, ultimately improving patient treatments and outcomes.